Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cisplatin: the future

R L Comis1

  • 1Department of Medical Science, Fox Chase Cancer Center, Philadelphia, PA.

Seminars in Oncology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Cisplatin is a vital chemotherapy drug for various cancers, including testicular and ovarian. While effective, its toxicity necessitates ongoing research for safer, more potent alternatives in cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Future directions in the treatment of non-small cell lung cancer.

Seminars in oncology·2000
Same author

The role of oral etoposide in non-small cell lung cancer.

Drugs·2000
Same author

The Cooperative Groups: past and future.

Cancer chemotherapy and pharmacology·1998
Same author

Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors.

Cancer·1998
Same author

Small-cell lung cancer: a perspective on the past and a preview of the future.

Oncology (Williston Park, N.Y.)·1998
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Cisplatin is a cornerstone chemotherapy agent, critical for treating testicular, ovarian, lung, and bladder cancers.
  • Its analogue, carboplatin, offers a better toxicity profile but still presents challenges like thrombocytopenia.

Purpose of the Study:

  • To review the current role and future prospects of cisplatin in cancer therapy.
  • To highlight the ongoing need for novel platinating agents with improved efficacy and reduced toxicity.

Main Methods:

  • Literature review of cisplatin's clinical applications and toxicities.
  • Discussion of carboplatin's advantages and limitations.
  • Exploration of ongoing research into new platinum-based compounds.

Main Results:

Related Experiment Videos

  • Cisplatin remains a primary treatment for several malignancies and a key component in clinical trials.
  • Carboplatin's use is limited by thrombocytopenia, requiring supportive care.
  • Laboratory research continues to investigate platinum compound pharmacodynamics.

Conclusions:

  • Cisplatin will remain important in cancer treatment in the short term.
  • The development of new platinum-based drugs with reduced toxicity and broader activity is essential for the future of cancer therapy.